Nonclinical Toxicology
We perform pharmacokinetic (PK) studies to assess the absorption, distribution, metabolism and excretion (ADME) profile of their compounds. These in vivo studies provide crucial data for understanding systemic exposure and supporting dose selection in regulatory toxicology programs.
Preclinical regulatory CRO
Established – 2000
Our PK studies are designed to help predict a compound’s behavior in the body, detect potential issues early, and inform decisions about dosing and safety margins. These studies are typically carried out in rodent and non-rodent species using various administration routes and biological matrices.
Pharmaceutical
Chemical
Biotechnological
Advanced Therapy Medical Products (ATMPs)
Vivotecnia has a highly specialized bioanalytical unit that combines state-of-the-art technology with a multidisciplinary team of experts in regulated preclinical studies.
SCIEX Triple Quad™ LC-MS/MS, UPLC, HPLC, NanoLC 400 and robotic automation systems for sample handling.
Provantis® platform for document control, traceability and regulatory compliance.
Professionals with experience in more than 4,000 preclinical studies, including mutagenicity, toxicity and pharmacokinetics.
All assays are performed under GLP certification and are audited by our internal Quality Assurance unit.
Need fast and reliable PK data to support your development? Contact our pharmacokinetics team to design a customized study that fits your compound’s needs
We use cookies to improve your experience on this website. You may choose which types of cookies to allow and change your preferences at any time. Disabling cookies may impact your experience on this website. You can learn more by viewing our Cookie Policy.